🇺🇸 FDA
Patent

US 7902148

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

granted A61KA61K31/33A61K38/12

Quick answer

US patent 7902148 (Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent) held by Theravance, Inc. expires Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Mar 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/33, A61K38/12, A61P, A61P31/04